An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures

Stem Cell Research

Volumn 13, Issue 2, 2014, Pages 202-213

  Ting, Sherwin ^a   Chen, Allen ^a   Reuveny, Shaul ^a   Oh, Steve ^a  

^a AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MYOSIN HEAVY CHAIN; TROPONIN T; BIOLOGICAL MARKER; CARDIOTONIC AGENT; GLUTAMINE; ISOPRENALINE;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL SUSPENSION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; GLUCOSE INTAKE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HYDRODYNAMICS; IMMUNOFLUORESCENCE; LARGE SCALE PRODUCTION; MICROCARRIER CULTURE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SHEAR STRESS; STEM CELL EXPANSION; SUSPENSION CELL CULTURE; CELL CULTURE; CELL PROLIFERATION; CULTURE TECHNIQUE; DEVICES; DRUG EFFECTS; EMBRYONIC STEM CELL; EQUIPMENT DESIGN; HEART CONTRACTION; MECHANICAL STRESS; MECHANOTRANSDUCTION; METABOLISM; MOTION; PHENOTYPE; PHYSIOLOGY; TIME;

BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; EQUIPMENT DESIGN; GLUCOSE; GLUTAMINE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; ISOPROTERENOL; MECHANOTRANSDUCTION, CELLULAR; MOTION; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; PHENOTYPE; STRESS, MECHANICAL; TIME FACTORS; TROPONIN T;

EID: 84904576306     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.06.002     Document Type: Article

References (46)

1. Burridge P.W., Thompson S., Millrod M.A., Weinberg S., et al. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS ONE 2011, 6:e18293.
2. Burridge P.W., Keller G., Gold J.D., Wu J.C. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 2012, 10:16-28.
3. Chen X., Chen A., Woo T.L., Choo A.B., et al. Investigations into the metabolism of two-dimensional colony and suspended microcarrier cultures of human embryonic stem cells in serum-free media. Stem Cells Dev. 2010, 19:1781-1792.
4. Chen A.K., Chen X., Choo A.B., Reuveny S., et al. Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell Res. 2011, 7:97-111.
5. Chen A., Ting S., Seow J., Reuveny S., et al. Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells. Stem Cell Res. Ther. 2014, 5:12.
6. Choo A., Padmanabhan J., Chin A., Fong W.J., et al. Immortalized feeders for the scale-up of human embryonic stem cells in feeder and feeder-free conditions. J. Biotechnol. 2006, 122:130-141.
7. Choo A.B., Tan H.L., Ang S.N., Fong W.J., et al. Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells 2008, 26:1454-1463.
8. Chung S., Dzeja P.P., Faustino R.S., Perez-Terzic C., et al. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat. Clin. Pract. Cardiovasc. Med. 2007, 4(Suppl. 1):S60-S67.
9. Earls J.K., Jin S., Ye K. Mechanobiology of human pluripotent stem cells. Tissue Eng. Part B Rev. 2013, 19:420-430.
10. Freund C., Ward-van Oostwaard D., Monshouwer-Kloots J., van den Brink S., et al. Insulin redirects differentiation from cardiogenic mesoderm and endoderm to neuroectoderm in differentiating human embryonic stem cells. Stem Cells 2008, 26:724-733.
11. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., et al. Executive summary: heart disease and stroke statistics - 2014 update: a report from the American Heart Association. Circulation 2014, 129:399-410.
12. Graichen R., Xu X., Braam S.R., Balakrishnan T., et al. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 2008, 76:357-370.
13. Itskovitz-Eldor J., Schuldiner M., Karsenti D., Eden A., et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med. 2000, 6:88-95.
14. Jing D., Parikh A., Canty J.M., Tzanakakis E.S. Stem cells for heart cell therapies. Tissue Eng. Part B Rev. 2008, 14:393-406.
15. Kattman S.J., Witty A.D., Gagliardi M., Dubois N.C., et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011, 8:228-240.
16. Kinney M.A., Sargent C.Y., McDevitt T.C. The multiparametric effects of hydrodynamic environments on stem cell culture. Tissue Eng. Part B Rev. 2011, 17:249-262.
17. Kirouac D.C., Zandstra P.W. The systematic production of cells for cell therapies. Cell Stem Cell 2008, 3:369-381.
18. Kurosawa H. Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells. J. Biosci. Bioeng. 2007, 103:389-398.
19. Lecina M., Ting S., Choo A., Reuveny S., et al. Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. Tissue Eng. Part C Methods 2010, 16:1609-1619.
20. Leung H.W., Chen A., Choo A.B., Reuveny S., et al. Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures. Tissue Eng. Part C Methods 2011, 17:165-172.
21. Lian X., Hsiao C., Wilson G., Zhu K., et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E1848-E1857.
22. Lian X., Zhang J., Azarin S.M., Zhu K., et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat. Protoc. 2013, 8:162-175.
23. Lopaschuk G.D., Jaswal J.S. Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J. Cardiovasc. Pharmacol. 2010, 56:130-140.
24. Metallo C.M., Vodyanik M.A., de Pablo J.J., Slukvin I.I., et al. The response of human embryonic stem cell-derived endothelial cells to shear stress. Biotechnol. Bioeng. 2008, 100:830-837.
25. Minami I., Yamada K., Otsuji T.G., Yamamoto T., et al. A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Rep. 2012, 2:1448-1460.
26. Niebruegge S., Nehring A., Bar H., Schroeder M., et al. Cardiomyocyte production in mass suspension culture: embryonic stem cells as a source for great amounts of functional cardiomyocytes. Tissue Eng. Part A 2008, 14:1591-1601.
27. Niebruegge S., Bauwens C.L., Peerani R., Thavandiran N., et al. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol. Bioeng. 2009, 102:493-507.
28. Nsiah B.A., Ahsan T., Griffiths S., Cooke M., et al. Fluid shear stress pre-conditioning promotes endothelial morphogenesis of embryonic stem cells within embryoid bodies. Tissue Eng. Part A 2014, 20:954-965.
29. Oh S.K., Chen A.K., Mok Y., Chen X., et al. Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res. 2009, 2:219-230.
30. Oncul A.A., Kalmbach A., Genzel Y., Reichl U., et al. Characterization of flow conditions in 2L and 20L wave bioreactors using computational fluid dynamics. Biotechnol. Prog. 2010, 26:101-110.
31. Peerani R., Rao B.M., Bauwens C., Yin T., et al. Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J. 2007, 26:4744-4755.
32. Placzek M.R., Chung I.M., Macedo H.M., Ismail S., et al. Stem cell bioprocessing: fundamentals and principles. J. R. Soc. Interface 2009, 6:209-232.
33. Rowley J., Abraham E., Campbell A., Brandwein H., et al. Meeting lot-size challenges of manufacturing adherent cells for therapy. BioProcess Int. 2012, 10:16-22.
34. Sa S., McCloskey K.E. Stage-specific cardiomyocyte differentiation method for H7 and H9 human embryonic stem cells. Stem Cell Rev. 2012, 8:1120-1128.
35. Santos F., Andrade P.Z., Abecasis M.M., Gimble J.M., et al. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions. Tissue Eng. Part C Methods 2011, 17:1201-1210.
36. Sucosky P., Osorio D.F., Brown J.B., Neitzel G.P. Fluid mechanics of a spinner-flask bioreactor. Biotechnol. Bioeng. 2004, 85:34-46.
37. Ting S., Lecina M., Chan Y.C., Tse H.F., et al. Nutrient supplemented serum-free medium increases cardiomyogenesis efficiency of human pluripotent stem cells. World J. Stem Cells 2013, 5:86-97.
38. Ting S., Liew S.J., Japson F., Shang F., et al. Time-resolved video analysis and management system for monitoring cardiomyocyte differentiation processes and toxicology assays. Biotechnol. J. 2014, 9:675-683.
39. Tohyama S., Hattori F., Sano M., Hishiki T., et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 2013, 12:127-137.
40. Wang D., Liu W., Han B., Xu R. The bioreactor: a powerful tool for large-scale culture of animal cells. Curr. Pharm. Biotechnol. 2005, 6:397-403.
41. Wang H., Li M., Lin P.H., Yao Q., et al. Fluid shear stress regulates the expression of TGF-beta1 and its signaling molecules in mouse embryo mesenchymal progenitor cells. J. Surg. Res. 2008, 150:266-270.
42. Willems E., Spiering S., Davidovics H., Lanier M., et al. Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circ. Res. 2011, 109:360-364.
43. Xu C. Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells. J. Mol. Cell. Cardiol. 2012, 52:1203-1212.
44. Yang L., Soonpaa M.H., Adler E.D., Roepke T.K., et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
45. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
46. Zwi L., Caspi O., Arbel G., Huber I., et al. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 2009, 120:1513-1523.